| Apoptosis Compound Library A unique collection of 136 natural compounds inhibitors used for cancer/apoptosis research. |
Featured Products
- Sinapine
- 5-O-Feruloylquinic acide
- Ganoderic acid DM
- alpha-Spinasterol
- Delta 5-avenasterol
- 3-O-Feruloylquinic acid
- Ginsenoside Rg5
- 5-O-Feruloylquinic acide
- Gomisin N
- Decursin
- 3,6'-Disinapoyl sucrose
- Isochlorogenic acid A
- Schaftoside
- 20R-Ginsenoside Rg2
- A-20R-Ginsenoside Rg2
- Ginsenoside Compound K
- 11-Keto-beta-boswellic acid
- Ganoderol A
- Ganoderol B
- Ganoderiol F
- Cyanidin-3-O-glucoside chloride
- Ginsenoside Rk2
- Ginsenoside Rh3
- Ginsenoside Re
- Salvianolic acid B
- Tenuifolin
- Onjisaponin B
- 1,18-Octadecanediol
- Prosapogenin CP4
- Prosapogenin CP6
Related Products
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- The products in the BioCrick screening libraries are all from plants.
- The biological activities or pharmacological activities of all the BioCrick products are derived from the databases of all over the world the latest literatures, patent reports and clinical validation, you can according to the product manuals on our website to access the relevant literatures, hope that our informations can give some inspirations and help to your research.
- The collections of unique natural products, which include antioxidants, anti-inflammatory, antibacterial, anticancer, and ect. Can be used for high throughput screening (HTS) and high content screening (HCS), is to help you carry out new drug screening, the emergence of new indications and other professional tools.
- Available in stock with overnight delivery and free shipping over $500
- A valuable tool for chemical genomics, epigenetic target identification in pharmacogenomics, and other biological applications.
- Potent, selective and cell-permeable in inhibiting or activating target molecules
- Bioactivity and safety confirmed by preclinical research and clinical trials.
- Detailed files describing potency, selectivity and applications etc.
- Structurally diverse, medicinally active, and cell permeable.
- NMR and HPLC validated to ensure the highest purity.
| Form | Pre-dissolved DMSO solutions | Stability | -20°C: 12 months -80°C: 24 months |
| Packaging | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37°C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. | ||
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
||
Plate layout: BCL0004
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | Q-VD-OPh hydrate | Z-VAD-FMK | Boc-D-FMK | Z-DEVD-FMK | Caspase-3/7 Inhibitor I | Apoptosis Inhibitor | Bendamustine HCl | Nutlin-3b | ABT-263 (Navitoclax) | AT-406 (SM-406) | Empty |
| b | Empty | 3,3'-Diindolylmethane | AT-101 | BAM7 | Brassinolide | D609 | LCL161 | Lenalidomide hydrochloride | Necrostatin 2 | Nutlin-3a chiral | p53 and MDM2 proteins-interaction-inhibitor chiral | Empty |
| c | Empty | p53 and MDM2 proteins-interaction-inhibitor racemic | Pemetrexed disodium hemipenta hydrate | R1530 | RG7112 | RG7388 | SMIP004 | SPK-601 | Trabectedin | WEHI-539 | YM-155 hydrochloride | Empty |
| d | Empty | Necrostatin 2 racemate | Necrostatin 2 S enantiomer | Apoptosis Activator 2 | 2-Methoxyestradiol (2-MeOE2) | Obatoclax mesylate (GX15-070) | BM-1074 | Sabutoclax | Apogossypolone (ApoG2) | RITA (NSC 652287) | Tenovin-1 | Empty |
| e | Empty | JNJ-26854165 (Serdemetan) | Pifithrin-α (PFTα) | NSC 319726 | NSC 207895 (XI-006) | Lenalidomide (CC-5013) | Pomalidomide (CC-4047) | Necrostatin-1 | Birinapant (TL32711) | YM155 | GDC-0152 | Empty |
| f | Empty | Nutlin-3 | NSC 66811 | TW-37 | AZ 10417808 | Ivachtin | Ac-LEHD-AFC | PETCM | R18 | 2,3-DCPE hydrochloride | Actinomycin D | Empty |
| g | Empty | C 75 | CHM 1 | Mitomycin C | NSC 687852 (b-AP15) | Bax channel blocker | iMAC2 | Muristerone A | Cesium chloride | GRI 977143 | Mdivi 1 | Empty |
| h | Empty | Melphalan | NQDI 1 | TLQP 21 | CP 31398 dihydrochloride | Cyclic Pifithrin-α hydrobromide | HLI 373 | MIRA-1 | NSC 146109 hydrochloride | PhiKan 083 | Pifithrin-μ | Empty |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a | Empty | PRIMA-1 | PRIMA-1MET | RETRA hydrochloride | SJ 172550 | WR 1065 | HA14-1 | PAC-1 | ABT-737 | ABT-199 | Cycloheximide | Empty |
| b | Empty | Triflurdine (Viroptic) | Tenovin-3 | CID 755673 | ONC201 | AMG232 | SM-164 | Marinopyrrole A | Lenalidomide hemihydrate | PM00104 | Doxifluridine | Empty |
| c | Empty | Z-IETD-FMK | Z-LEHD-FMK | Meisoindigo | Omaveloxolone (RTA-408) | CDDO-EA | Roquinimex | Emricasan | BV6 | NVP-CGM097 | Mcl1-IN-1 | Empty |
| d | Empty | YH239-EE | Raltegravir potassium salt | Epibrassinolide | Pifithrin-β | UMI-77 | (+)-Apogossypol | MI-773 (SAR405838) | Radotinib(IY-5511) | Nolatrexed (AG-337) | A-1210477 | Empty |
| e | Empty | PD-1/PD-L1 inhibitor 2 | NSC59984 | Necrosulfonamide | CFM 4 | UC 112 | RHC 80267 | Capsaicin | Cisplatin | Gambogic acid | Plumbagin | Empty |
| f | Empty | Embelin | Streptozotocin | Piplartine | Deguelin | Atractyloside potassium salt | Matrine | Empty | Empty | Empty | Empty | Empty |
| g | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
| h | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty | Empty |
